Question 1

What is Matt Schmidt?

Accepted Answer

Matt Schmidt is a Person.

Question 2

How often does Matt Schmidt appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 8 articles.

Question 3

When was Matt Schmidt first tracked by Ergen?

Accepted Answer

First tracked on Apr 13, 2026.

Question 4

When was Matt Schmidt last mentioned in news?

Accepted Answer

Last active on May 14, 2026.

Question 5

What is Matt Schmidt's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Matt Schmidt in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Matt Schmidt?

Accepted Answer

Sirtex Medical DOORwaY90 Study Success (Apr 13, 2026, 8 articles).

Question 8

How did the "Sirtex Medical DOORwaY90 Study Success" event impact Matt Schmidt?

Accepted Answer

Matt Schmidt, CEO of China Grand Pharmaceutical — Sirtex Medical, expressed confidence that the DOORwaY90 study results would redefine expectations for Y-90 therapy and expand treatment possibilities for patients with unresectable HCC.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.